DAWN

Day One Biopharmaceuticals, Inc.

Company with tickers: DAWN

CIK

1845337

CUSIP

23954D109

Shares Outstanding

103,334,169

13F Activity (30d)

149 filings 145 filers

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value
2026-04-23	Bender Jeremy	Director	Other	81,816	—	—
2026-04-23	York Charles N II	Chief Financial Officer and VP	Other	162,000	—	—
2026-04-23	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Other	90,000	—	—
2026-04-23	Bender Jeremy	Director	Other	147,702	—	—
2026-04-23	Merendino Lauren	Chief Commercial Officer	Other	40,565	—	—
2026-04-23	Ramasastry Saira	Director	Other	28,700	—	—
2026-04-23	Merendino Lauren	Chief Commercial Officer	Other	18,978	—	—
2026-04-23	Dable Habib J	Director	Other	32,335	—	—
2026-04-23	Garland J. Scott	Director	Other	37,500	—	—
2026-04-23	Josey John A.	Director	Other	37,500	—	—
2026-04-23	Bender Jeremy	Director	Other	355,000	—	—
2026-04-23	Garland J. Scott	Director	Other	48,072	—	—
2026-04-23	Josey John A.	Director	Other	15,000	—	—
2026-04-23	Holles Natalie C.	Director	Other	57,310	—	—
2026-04-23	Ramasastry Saira	Director	Other	47,581	—	—
2026-04-23	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Other	65,625	—	—
2026-04-23	Dable Habib J	Director	Other	22,500	—	—
2026-04-23	Bender Jeremy	Director	Other	222,188	—	—
2026-04-23	York Charles N II	Chief Financial Officer and VP	Other	312,025	—	—
2026-04-23	Grossman William	Director	Other	32,335	—	—
2026-04-23	Merendino Lauren	Chief Commercial Officer	Other	25,816	—	—
2026-04-23	VASCONCELLES MICHAEL	Director	Other	106,875	—	—
2026-04-23	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Other	8,889	—	—
2026-04-23	Merendino Lauren	Chief Commercial Officer	Other	330,200	—	—
2026-04-23	Grossman William	Director	Other	66,660	—	—
2026-04-23	Bender Jeremy	Director	Other	397,000	—	—
2026-04-23	York Charles N II	Chief Financial Officer and VP	Other	188,000	—	—
2026-04-23	Holles Natalie C.	Director	Other	22,500	—	—
2026-04-23	York Charles N II	Chief Financial Officer and VP	Other	497,667	—	—
2026-04-23	Holles Natalie C.	Director	Other	28,700	—	—
2026-04-23	Bender Jeremy	Director	Other	244,000	—	—
2026-04-23	Dable Habib J	Director	Other	15,000	—	—
2026-04-23	Bender Jeremy	Director	Other	286,000	—	—
2026-04-23	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Other	72,694	—	—
2026-04-23	Josey John A.	Director	Other	1,181	—	—
2026-04-23	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Other	309,000	—	—
2026-04-23	VASCONCELLES MICHAEL	Director	Other	226,000	—	—
2026-04-23	Merendino Lauren	Chief Commercial Officer	Other	90,000	—	—
2026-04-23	Holles Natalie C.	Director	Other	37,500	—	—
2026-04-23	York Charles N II	Chief Financial Officer and VP	Other	72,875	—	—
2026-04-23	Garland J. Scott	Director	Other	22,500	—	—
2026-04-23	Merendino Lauren	Chief Commercial Officer	Other	60,157	—	—
2026-04-23	Josey John A.	Director	Other	28,700	—	—
2026-04-23	York Charles N II	Chief Financial Officer and VP	Other	46,375	—	—
2026-04-23	Ramasastry Saira	Director	Other	40,000	—	—
2026-04-23	Garland J. Scott	Director	Other	28,700	—	—
2026-04-23	Nicholson Garry A	Director	Other	37,500	—	—
2026-04-23	Josey John A.	Director	Other	22,500	—	—
2026-04-23	Ramasastry Saira	Director	Other	22,500	—	—
2026-04-23	Grossman William	Director	Other	22,500	—	—

Showing 1–50 of 1,045 transactions